Shanghai Haohai Biological Technology Co., Ltd.
Symbool: 6826.HK
HKSE
42.45
HKDMarktprijs vandaag
15.1027
Koers/Winst Verhouding
0.7575
Koers/Winst Groei Verhouding
16.43B
MRK Kapitalisatie
- 0.01%
DIV Rendement
Shanghai Haohai Biological Technology Co., Ltd. (6826-HK) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2751.1 | 2541.7 | 2907.2 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 11.1 | 6.7 | 6.4 | ||||||||||
balance-sheet.row.net-receivables | 0 | 447.6 | 471.1 | 375.2 | ||||||||||
balance-sheet.row.inventory | 0 | 526.2 | 485.2 | 354.8 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 25.2 | 34.1 | 69.6 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 3750.1 | 3532.1 | 3712.6 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1553 | 1409.6 | 1248.9 | ||||||||||
balance-sheet.row.goodwill | 0 | 413 | 411.2 | 406.9 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 729.1 | 783.5 | 783.1 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1142.1 | 1194.7 | 1190 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 596 | 664.7 | 619 | ||||||||||
balance-sheet.row.tax-assets | 0 | 53.1 | 59.3 | 49.4 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | 11.1 | 32 | 130.5 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3355.4 | 3360.3 | 3237.8 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 7105.5 | 6892.4 | 6950.4 | ||||||||||
balance-sheet.row.account-payables | 0 | 55.1 | 54.5 | 46.3 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 216.6 | 34.4 | 66 | ||||||||||
balance-sheet.row.tax-payables | 0 | 58.4 | 52.1 | 17.8 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 191.3 | 83.9 | 39.5 | ||||||||||
Deferred Revenue Non Current | 0 | 13.6 | 5.5 | 9.4 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 444.2 | 422.4 | 375 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 372.3 | 478.7 | 402.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 54.2 | 61.3 | 46.7 | ||||||||||
balance-sheet.row.total-liab | 0 | 1088.2 | 990 | 890.1 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 71.7 | 47 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 171.5 | 174.1 | 175.8 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 2728.6 | 2369.5 | 2309.7 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -71.7 | -47 | 47.9 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2750 | 2971 | 3180 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5650.1 | 5514.6 | 5713.5 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7105.5 | 6892.4 | 6950.4 | ||||||||||
balance-sheet.row.minority-interest | 0 | 367.2 | 387.8 | 346.8 | ||||||||||
balance-sheet.row.total-equity | 0 | 6017.3 | 5902.4 | 6060.3 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 607.1 | 671.4 | 625.3 | ||||||||||
balance-sheet.row.total-debt | 0 | 407.9 | 118.3 | 105.5 | ||||||||||
balance-sheet.row.net-debt | 0 | -2332.1 | -2423.5 | -2795.3 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 508.3 | 235.7 | 382.6 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 197.9 | 204.2 | 162.8 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | -81.6 | 0 | 0 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 14.3 | 30.2 | 0 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 73.2 | -183.5 | 23.9 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | -52.3 | -41.9 | ||||||||||
cash-flows.row.inventory | 0 | -48.4 | -138.9 | -28.6 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 52.3 | 41.9 | ||||||||||
cash-flows.row.other-working-capital | 0 | 121.6 | -44.6 | 52.6 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | -77.6 | -55.4 | -227.1 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -267.2 | -317.1 | -272.1 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 1.6 | 14.7 | -83.3 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | -204.2 | -528.8 | -696.6 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 14.6 | 9.1 | 749.3 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 78.6 | 140.4 | 154.6 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -376.6 | -681.8 | -148.1 | ||||||||||
cash-flows.row.debt-repayment | 0 | -16.4 | -47.9 | -95.5 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 73.7 | 0 | -4 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | -270 | -147.7 | -44.9 | ||||||||||
cash-flows.row.dividends-paid | 0 | -68.5 | -121.9 | -87.9 | ||||||||||
cash-flows.row.other-financing-activites | 0 | -245.7 | 29.1 | 1.1 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -257.7 | -288.4 | -231.3 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 10 | 14.2 | -6.9 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | 10.1 | -724.7 | -44 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 569.3 | 559.2 | 1283.9 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 559.2 | 1283.9 | 1327.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | 634.5 | 231.3 | 342.3 | ||||||||||
cash-flows.row.capital-expenditure | 0 | -267.2 | -317.1 | -272.1 | ||||||||||
cash-flows.row.free-cash-flow | 0 | 367.2 | -85.9 | 70.2 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 2634.9 | 2103.4 | 1750.1 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 781.4 | 656.5 | 490.4 | ||||||||||
income-statement-row.row.gross-profit | 0 | 1853.5 | 1446.9 | 1259.7 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | -4 | -40.3 | -33.9 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 1415.1 | 1226.8 | 1032.2 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2196.5 | 1883.3 | 1522.5 | ||||||||||
income-statement-row.row.interest-income | 0 | 77.7 | 87.9 | 98.2 | ||||||||||
income-statement-row.row.interest-expense | 0 | 7.3 | 7.6 | 5 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -4.7 | -22.9 | -1.8 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | -4 | -40.3 | -33.9 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | -4.7 | -22.9 | -1.8 | ||||||||||
income-statement-row.row.interest-expense | 0 | 7.3 | 7.6 | 5 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 197.9 | 204.2 | 162.8 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 513 | 258.7 | 384.4 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 508.3 | 235.7 | 382.6 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 96 | 45.4 | 35.4 | ||||||||||
income-statement-row.row.net-income | 0 | 416.1 | 180.5 | 352.2 |
Vaak gestelde vragen
Wat is Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) totale activa?
Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) totale activa is 7105497000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.698.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.162.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.177.
Wat is Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) nettowinst (netto-inkomen)?
De nettowinst is 416121000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 407949000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 1415132000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.